Prolong International Corp. Announces Q4 and Year-End Results
IRVINE, Calif.--March 15, 2001--Prolong International Corp. (AMEX:PRL) today reported that in its fourth quarter ended Dec. 31, 2000 it incurred a net loss of $1.3 million, or $0.04 per diluted share, on net sales of $2.5 million.In the fourth quarter of 1999 the company reported a net loss of $4.5 million, or $0.16 per diluted share, on net sales of $3 million.
For the year ended Dec. 31, 2000, the company reported a net loss of $1.7 million or $0.06 per diluted share, on sales of $19.1 million, compared with a net loss of $6.6 million, or $0.23 per diluted share on sales of $34.5 million in 1999.
Contributing to the fourth-quarter and year-to-date loss were lower revenues reflecting the recent soft market for the automotive after-market's specialty chemical category, which encompasses, among others, the company's signature Prolong Engine Treatment.
"Large promotional orders placed by some of our largest retail accounts, during 1999, but not duplicated during 2000, were also a factor in declining sales," said Elton Alderman, president and CEO of Prolong International.
Other factors cited included a decline in direct response television (DRTV) advertising, increased competition in the market place and also due to a decreased demand and acceptance of the appearance product line in Year 2000.
"As a result, the company initiated vigorous expense-reduction strategies during the Year 2000 to bring expenses in line with anticipated revenues," said Alderman.
"The company anticipates realizing the full impact of these expense reductions in Year 2001. The company also is redirecting its focus on sales strategies which promote the core lubricant product line. The cumulative financial benefits of these measures are integral to our plans for attaining sustained profitability and top-line growth during 2001."
PROLONG INTERNATIONAL CORP. Consolidated Condensed Statements of Operations Three Months Ended December 31, 2000 1999 (unaudited) (unaudited) Net sales $2,451,612 $2,961,240 Cost of sales 1,116,857 2,330,554 Gross profit 1,334,755 630,686 Selling and marketing expenses 1,997,723 4,944,795 General and administrative expenses 1,038,871 2,449,902 Research and development expenses 18,488 123,362 Other expenses, net (130,134) (154,949) Loss before taxes (1,850,461) (7,042,322) Benefit for income taxes (572,979) (2,562,926) Net loss ($1,277,482) ($4,479,396) Net loss per common share Basic ($0.04) ($0.16) Diluted ($0.04) ($0.16) Weighted average common shares Basic shares outstanding 28,438,903 28,445,835 Diluted shares outstanding 28,438,903 28,445,835 Year Ended December 31, 2000 1999 (audited) (audited) Net sales $19,080,218 $34,470,915 Cost of sales 5,257,600 10,500,586 Gross profit 13,822,618 23,970,329 Selling and marketing expenses 10,631,959 25,850,474 General and administrative expenses 4,709,504 7,645,321 Research and development expenses 104,089 305,297 Other expenses, net (526,589) (443,224) Loss before taxes (2,149,523) (10,273,987) Benefit for income taxes (497,245) (3,693,926) Net loss ($1,652,278) ($6,580,061) Net loss per common share Basic ($0.06) ($0.23) Diluted ($0.06) ($0.23) Weighted average common shares Basic shares outstanding 28,442,341 28,445,835 Diluted shares outstanding 28,442,341 28,445,835 Consolidated Condensed Balance Sheets December 31, December 31, 2000 1999 (audited) (audited) Assets: Cash and cash equivalents $ 126,917 $ 1,094,779 Accounts receivable, net 3,245,892 2,747,459 Inventories, net 970,236 2,171,728 Other current assets 1,453,514 2,001,613 Total current assets 5,796,559 8,015,579 Property and equipment, net 3,193,109 3,554,176 Intangible assets, net 6,529,986 7,036,670 Other assets 2,195,546 2,773,223 Total assets $17,715,200 $21,379,648 Liabilities and stockholders' equity: Accounts payable $ 2,183,482 $ 2,843,843 Accrued expenses and other current liabilities 1,663,060 1,256,572 Line of credit 2,050,716 3,985,000 Total current liabilities 5,897,258 8,085,415 Notes payable, noncurrent 2,277,130 2,327,048 Total stockholders' equity 9,540,812 10,967,185 Total liabilities and stockholders' equity $17,715,200 $21,379,648